Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

R.W. Merryman, H.T. Kim, P.L. Zinzani, C. Carlo-Stella, S.M. Ansell, M.-A. Perales, A. Avigdor, A.S. Halwani, R. Houot, T. Marchand, N. Dhedin, W. Lescaut, A. Thiebaut-Bertrand, S. François, A. Stamatoullas-Bastard, P.-S. Rohrlich, H.L. Wallet, L. Castagna, A. Santoro, V. BachanovaS.C. Bresler, A. Srivastava, H. Kim, E. Pesek, M. Chammas, C. Reynolds, V.T. Ho, J.H. Antin, J. Ritz, R.J. Soiffer, P. Armand

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1380-1388
Number of pages9
JournalBlood
Volume129
Issue number10
DOIs
Publication statusPublished - 2017

Cite this

Merryman, R. W., Kim, H. T., Zinzani, P. L., Carlo-Stella, C., Ansell, S. M., Perales, M-A., Avigdor, A., Halwani, A. S., Houot, R., Marchand, T., Dhedin, N., Lescaut, W., Thiebaut-Bertrand, A., François, S., Stamatoullas-Bastard, A., Rohrlich, P-S., Wallet, H. L., Castagna, L., Santoro, A., ... Armand, P. (2017). Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma. Blood, 129(10), 1380-1388. https://doi.org/10.1182/blood-2016-09-738385